Shaping the future of animal health
Virbac group

United States: in-house manufacturing of Virbac flagship parasiticide

Thursday, December 06, 2018 

Corporate news

United States: in-house manufacturing of Virbac flagship parasiticide

In August, the FDA approved the transfer of production to the Virbac St. Louis site (Missouri) of a parasiticide for dogs acquired by the company at the beginning of 2015. The complexity of the industrial extrusion process required all the skills and attention of the American subsidiary and the Group's Production/Quality teams for nearly three years.

cartouche-EN.png

Back

Share on Facebook Share on Google Print current page Share on Twitter